BackNemaura Medical Overview

Nemaura Medical Total Revenue

Latest total revenue for NMRD: $-1.6M, below the Healthcare sector average of $540B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

N/A

As of Dec 2023

Annual Revenue (TTM)

$-1553436.00
↓ 490.98% YoY

Trailing 12 months ending Dec 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Nemaura Medical (NMRD) FAQ

The latest total revenue for NMRD is $-1.6M as of December 2023. That compares with $400K in the prior-year period — down 491.0% year over year. That is below the Healthcare sector average of $540B. Investors often review this figure alongside Nemaura Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMRD's total revenue moved from $400K to $-1.6M — a 491.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nemaura Medical's operating scale or balance-sheet position.

Against Healthcare companies, NMRD currently prints $-1.6M for total revenue, while the sector average sits near $540B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nemaura Medical's growth, margins, and balance sheet.

A total revenue figure of $-1.6M for NMRD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $540B. Explore the charts below for those layers of context.

After noting NMRD's total revenue ($-1.6M), review year-over-year change from $400K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.